Key result
Ticagrelor pretreatment attenuated the increase in P2Y12 expression in superior cervical ganglions and the changes to the ion channel characteristics of SCG neurons after myocardial infarction.
Why the study?
The study aimed to determine changes in the ion channel characteristics of the superior cervical ganglion after myocardial infarction and evaluate the role of pretreatment with ticagrelor.
Does ticagrelor pretreatment attenuate changes in ion channel characteristics of superior cervical ganglion neurons after myocardial infarction in a rabbit model?
RCT (n=18)
Randomly divided
Does ticagrelor pretreatment attenuate changes in ion channel characteristics of superior cervical ganglion neurons after myocardial infarction in a rabbit model?
Ticagrelor pretreatment may exert cardioprotective effects by attenuating sympathetic nerve activity and ion channel changes in the superior cervical ganglion after myocardial infarction.
Ticagrelor may modulate post-MI SCG ion channels in rabbits; leaves open any clinical autonomic effects beyond platelet inhibition.
Background: The superior cervical ganglion (SCG) plays a key role in cardiovascular diseases. The aim of this study was to determine the changes in the ion channel characteristics of the SCG following myocardial infarction (MI) and the role of pretreatment with the P2Y12 receptor antagonist ticagrelor (TIC). Methods: A total of 18 male rabbits were randomly divided into a control group, MI group, and P2Y12 receptor antagonist (TIC) group (abbreviated as the TIC group). Rabbit MI was performed via two abdominal subcutaneous injections of 150 mg·kg−1·d−1 of isoproterenol (ISO) with an interval of 24 h. TIC pretreatment at 20 mg·kg−1·d−1 was administered via gavage for two consecutive days. The cardiac function of each group was evaluated with echocardiography. ADP receptor P2Y12 expressions in SCGs were determined using RT-PCR and immunofluorescence staining. Ion channel characteristics of SCG neurons were measured using a whole-cell patch clamp. Intracellular calcium concentrations for SCG neurons were measured using confocal microscopy. Results: Cardiac function was reduced in the rabbits of the MI group, the sympathetic nerve activity of SCGs was increased, and the current amplitude of the neuron ion channel was increased. MI led to alterations in the activation and inactivation characteristics of INa channels accompanied by increased expression of P2Y12 in SCGs. Most of these abnormalities were prevented by TIC pretreatment in the TIC group. Conclusions: TIC pretreatment could attenuate the increase in P2Y12 expression in SCGs and the changes to the ion channel characteristics of SCG neurons after MI. This may be the mechanism underlying the cardiac protective effects of TIC.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2023) conducted an RCT in Myocardial Infarction (n=18). Ticagrelor vs. Control group and MI group was evaluated on Ion channel characteristics of SCG neurons and P2Y12 expression. Ticagrelor pretreatment attenuated the increase in P2Y12 expression in superior cervical ganglions and the changes to the ion channel characteristics of SCG neurons after myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: